QIA.F : Summary for QIAGEN NV EO -,01 - Yahoo Finance

U.S. Markets open in 2 hrs 38 mins

Qiagen NV (QIA.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
25.50+0.02 (+0.10%)
As of 6:22 AM EST. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close25.48
Bid25.61 x 110000
Ask25.62 x 110000
Day's Range25.46 - 25.60
52 Week Range17.83 - 73.40
Avg. Volume2,375
Market Cap5.75B
PE Ratio (TTM)51.01
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire20 days ago

    HTG Molecular Diagnostics and QIAGEN Team Up to Advance Precision Diagnostics

    TUCSON, Ariz., and VENLO, the Netherlands, Nov. 16, 2016-- HTG Molecular Diagnostics, Inc., a provider of instruments and reagents for molecular profiling applications and QIAGEN Manchester Limited, a ...

  • PR Newswire27 days ago

    QIAGEN's GeneReader NGS System Streamlines Data Management for Labs

    HILDEN, Germany and CHARLOTTE, North Carolina, November 9, 2016 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a partnership with lab informatics company Genohm ...

  • PR Newswire27 days ago

    QIAGEN GeneReader NGS System to Relaunch in U.S. Market

    Frankfurt Prime Standard: QIA) today announced the validation of new and improved sequencing chemistry for its GeneReader NGS System, the world's first complete Sample to Insight solution making the benefits of next-generation sequencing (NGS) accessible to any laboratory. QIAGEN published new, excellent performance data of the QIAGEN GeneReader NGS System using the new sequencing chemistry and QIAGEN's GeneRead QIAact Actionable Insights Tumor Panel. Data generated from the GeneReader NGS System with the new chemistry showed 100% concordance with results of QIAGEN's FDA approved therascreen KRAS RGQ PCR assay, the company's CE-labelled therascreen RAS Extension Pyro Assay as well as with an alternative next-generation sequencing (NGS) sequencer from another vendor.